Abstract
Malignant melanoma displays a high degree of cellular plasticity during disease progression. Signals in the tumor microenvironment are believed to influence melanoma plasticity through changes in the epigenetic state to guide dynamic differentiation and de-differentiation. Here we uncover a relationship between geometric features at perimeter regions of melanoma aggregates, and reprogramming to a stem cell-like state through histone marks H3K4Me2 and H3K9Ac. Using an in vitro tumor microengineering approach, we find spatial enrichment of these histone modifications with concurrent expression of stemness markers. The epigenetic modifier PRDM14 overlaps with H3K9Ac and shows elevated expression in cells along regions of perimeter curvature. siRNA knockdown of PRDM14 abolishes the MIC phenotype suggesting a role in regulating melanoma heterogeneity. Our results suggest mechanotransduction at the periphery of melanoma aggregates may orchestrate the activity of epigenetic modifiers to regulate histone state, cellular plasticity, and tumorigenicity.
Subject terms: Biophysics, Cancer, Stem cells, Diseases
Junmin Lee et al. study the role of geometric features at the perimeter regions of melanoma aggregates in programming stem cell-like state through histone marks. They use a tumor microengineering approach in vitro and report a spatial enrichment of histone modifications with stemness markers. Their work uncovers a mechanotransduction signaling that regulates epigenetic modifiers to regulate tumorigenicity.
Introduction
Malignant transformation and metastatic spread are known to be mediated by both genetic abnormalities1 and epigenetic alterations2. Epigenetics, defined as heritable change in gene expression occurring independent of changes in primary DNA sequence, is strongly implicated in the underlying mechanisms of cancer progression3. Microenvironment-mediated epigenetic regulation of cancer-related gene expression through DNA methylation, histone modification, and chromatin compartments is now believed to take part in a broad spectrum of cancer behaviors ranging from initiation to phenotypic alteration4. Histone modifications, including methylation and acetylation are covalent post-translational modifications to histone proteins. These modifications allow histones to alter the structure of chromatin, resulting in transcriptional activation or repression, that affect changes in cell behavior. For example, histone H3 lysine 4 di/tri-methylation (H3K4me2/3) and histone H3 acetylation (H3ac) are generally associated with gene activation5, whereas H3K27me, which marks active cis-regulatory elements, is associated with gene inactivation6. The detection of cancer-specific changes through histone modifications as epigenetic biomarkers has potential for clinical prediction, diagnosis, and therapeutic development.
Malignant melanoma-initiating cells (MICs), also referred to as melanoma repopulating cells or melanoma stem cells, are a dynamic sub-populations of cells that may arise during progression with tumor initiating capacities7. Unlike the clonal evolution model describing how a single cell accumulates genetic and epigenetic changes until becoming a cancer tumor cell1, the cancer stem cell model suggests a hierarchical organization (unidirectional) of cancer cells, according to their tumorigenic potential that has important implications for cancer therapy with stem cell-specific treatment regimens8. However, accumulating evidence surrounding cancer plasticity supports a new emerging model of tumorigenicity, in which dynamic plasticity facilitates malignant cells to revert to a stem cell-like phenotype9. Recently, we and other groups have shown that cancer cells are more plastic than previously anticipated. For instance, conversion to a stem cell-like state has been guided by microenvironment-mediated epigenetic regulation of gene expression including factors such as pH10, radiation11, stiffness12, hypoxia13, and interfacial stress14. These microenvironment parameters are not mutually exclusive and likely integrate in a context-dependent fashion during progression to guide tumor heterogeneity underlying progression. Hence, we hypothesize that if tumor cells are put into a specific context which facilitates reprogramming to the MIC phenotype, specific histone modifications may be used to understand the mechanisms underlying phenotypic alterations during progression. Our use of microengineering based on soft lithography allows us to mimic aspects of the tumor microenvironment, thus effectively deconstructing the biophysical cues of stiffness and geometry to probe how these parameters provide a context to facilitate epigenetic reprogramming to a stem cell-like tumorigenic state.
Results
Geometric cues regulate histone methylation and acetylation in melanoma
To classify histones linked to epigenetic reprogramming from melanoma to the MIC state, we employed microengineered hydrogels that we previously demonstrated will coordinate enhancement of the MIC phenotype with spatial control (Supplementary Fig. 1). In our previous study, B16F0 murine melanoma cells cultured for five days expressed higher levels of MIC markers at the periphery of microaggregates, with stem cell-like characteristics demonstrated in vitro and in vivo14. To understand how geometric cues at the perimeter of microaggregates of melanoma cells will influence histone state, we characterized a panel of histone marks that are implicated in controlling oncogenic gene activation. We first analyzed methylation state at Histone H3; H3K4me1/2/3 were studied because these are known as active histone marks5. In addition, Jarid1B (gene name: KDM5B) was also investigated because it is a common molecular marker of MICs, and is the histone lysine demethylase for H3K4me1/2/3 with pronounced roles in different cancer types15. For example, overexpression of Jarid1B in the MDA-MB 231 breast cancer cells suppressed malignant characteristics such as cell migration and invasion16, while overexpression of Jarid1B in melanoma17 or immortalized normal breast cancer cells (MCF10A)18 was found to enhance metastatic progression or cell invasion, respectively. Another representative histone mark associated with transcriptional activation, histone H3 lysine 36 di-methylation (H3K36me2), and a histone mark correlated with transcriptional repression, histone H3 lysine 9 tri-methylation (H3K9me3), were also employed.
We cultured cells for five days on five different micropatterned hydrogel substrates with the same area (50,000 μm2) or on non-patterned protein-stamped hydrogel substrates (10 kPa gels for both patterned and non-patterned) and immunostained for histone methylation state (Fig. 1a; Supplementary Fig. 2a, b). Interestingly, H3K4me2 and H3K36me2 expression co-localized with cells adopting the MIC phenotype at the periphery of microaggregates. We selected cells cultured for five days in the spiral shape for flow cytometry analysis because we previously found that this shape will augment the MIC phenotype19 through high interfacial boundary (perimeter/area) and high curvature14 (Supplementary Fig. 3). Similar to the immunofluorescence results, cells cultured in the spiral patterns display higher levels of H3K4me2 and H3K36me2 expression compared to those cultured on non-patterned surfaces (Fig. 1b; Supplementary Fig. 2c). To gain an understanding into the mechanism underlying the observed spatial distribution of histone marks, cells were grown in circular shapes, followed by quantification of histone marks in two different regions (outside and inside) within the same area. For the quentification, we employed the circular shapes in order to easily discern differences between two different regions (outside and inside) within the same area. Cells cultured at the perimeter displayed significantly higher levels of H3K4me2 compared to those cultured at central regions (Fig. 1c; Supplementary Fig. 2d), suggesting that regulation of gene expression associated with reprogramming of melanoma cells into the MIC phenotype could be linked to the H3K4me2 mark.
Histone acetylation is also an important modification in regulating chromatin accessibility and regulation of gene expression20, and various histone acetylation states have been shown to control gene expression during cancer progression21. To probe acetylation activity in our micropatterned cultures, we selected a panel of class I histone deacetylases (HDAC) and measured global acetylation of lysine (AcK), and histone H3 lysine 4 and 9 (H3K4ac and H3K9ac) marks which are associated with gene activation. By applying the same process for identifying methylation states involved in perimeter activation of MICs, we found that cells cultured at the periphery of different shapes expressed higher levels of HDAC1, AcK, H3K4ac, H3K9ac, and lower levels of HDAC3 compared to those cultured at central regions (Fig. 2a; Supplementary Fig. 4a, b). Flow cytometry of cells cultured in spiral patterns or on non-patterned substrates supported these immunofluorescence results (Fig. 2b; Supplementary Fig. 4c). Regional analysis reveals that cells cultured at the periphery of shapes exhibit significant elevation of the H3K9ac mark (Fig. 2c, d; Supplementary Fig. 4d, e), corresponding to higher expression levels of MIC and stemness markers (Supplementary Fig. 5). AcK and histone marks H3K4ac showed perimeter enhancement, although the difference was not statistically significant. We also immunostained cells cultured along straight lines and ring shapes where curvature (the convex curvature at the exterior of the torus shapes) and perimeter/area ratio can be varied. After five days in culture, we see cells show higher levels of H3K9ac with increased perimeter curvature and P/A, with a modest reduction in HDAC3 expression, although the difference is not statistically significant. While preliminary, this result supports a potential role for HDAC3 in deacetylating H3K9ac (Fig. 2e; Supplementary Fig. 6).
To investigate the role of Jarid1B, a histone demethylase for H3K4me1/2/3 and an established molecular marker for MICs15 in demethylase activity associated with the stem cell-like state, we cultured B16F0 cells in spiral geometries with small interfering RNA (siRNA) of Jarid1B with scrambled siRNA as control. siRNA concentration and delivery time were adjusted to ensure cells in control and experimental conditions reached approximately the same confluence. After five days in culture, we performed gene expression analysis using quantitative polymerase chain reaction (qPCR) of a panel of markers associated with the MIC state (CD271, SOX2, OCT4, and Nanog). We acknowledge that these markers and the existence of the MIC state are controversial; however these markers are accepted regulators of stemness phenotypes. We see a lower degree of transcript expression for markers associated with stemness for cells cultured with Jarid1B siRNA, except for transcript expression of CD271 at the siRNA concentration of 25 nM (Supplementary Fig. 7a–f). To evaluate the potential role of Jarid1B in regulating the H3K4me1/2/3 histone marks across spatial regions, we performed immunofluorescence staining of H3K4me1/2/3 for cells cultured in circular shapes, treated with Jarid1B or scrambled siRNA. Jarid1b knockdown does not change the levels of H3K4me2, while leading to an increase in the H3K4me3. This suggests Jarid1b is involved in demethylation of H3K4 but not necessarily associated with regulation of the MIC state at geometric features (Supplementary Fig. 7g–i). Interestingly, we also see a lower degree of transcript expression of HDAC1 for cells cultured with Jarid1B siRNA (Supplementary Fig. 7e), this may be because HDAC1 is one of the nucleosome remodeling and deacetylase (NuRD) complex which physically and functionally interacts with Jarid1B for transcriptional remodeling15 and one of the EMT-inducing genes (Snail) when complexed with HDAC222.
Histone 3 lysine 4 di-methylation and lysine 9 acetylation regulates oncogenic gene expression
To understand the possible mechanisms underlying changes in cell state on account of specific histone marks, B16 melanoma cells were grown on spiral patterned (reprogramming) or non-patterned (control) hydrogel substrates for five days, followed by chromatin immunoprecipitation and DNA sequencing (ChIP-seq). ChIP assays specific for the identified histone marks (H3K4me2/H3K9ac) were performed and differential ChIP peaks were identified with at least a 2-fold change and 0.001 FDR cutoff (Fig. 3a, b). More differential H3K4me2 (57.3%)/H3K9ac (77.8%) peaks were shown for the cells cultured in spiral geometries. To gain insights into potential regulators at these differential sites such as DNA-binding transcription factors, we also performed motif enrichment analysis. We found that differential peaks in spiral patterned versus non-pattered cells are enriched for distinct motif families; ERG (ETS)/Pit1/SOX2/9 (reprogramming) or ETS1/TcFap2e1/USF2 (control) for H3K4me2 differential peaks and ERG (ETS)/SOX10/MITF (reprogramming) or RBPJ/Nur77/Nkx2 (control) for H3K9ac differential peaks. ETS genes are known to be linked to p38/ERK mitogen-activated protein kinases (MAPK) signaling for tumor growth and progression23. For example, ETS1 could promote the development and invasion of malignant melanoma24, and when it associated with RhoC (also enriched for cells on spiral patterned hydrogels), melanoma cells could be progressive and metastatic25. Although the ETS family was also a top ranked motif for H3K4me2 peaks in non-patterned cells, enriched gene annotation associated with the differential peaks (Supplementary Figs. 8 and 9a) suggest a distinct role in coordinating the MIC phenotype. Pit1 is also known to upregulate Snai1, leading to tumor epithelial-mesenchymal transition (EMT) and their growth and metastasis26. Similar trends were observed for H3K9ac peaks but it has more distinct and specific differences between cells cultured on spiral patterned and non-patterned hydrogel substrates (Fig. 3b). We acknowledge that our data show a correlation between the geometry and the histone marks but may not indicate a causative role. First, we found over 50 predictive transcription factor motifs associated with H3K9ac differential peaks for patterned cells over non-patterned cells (top 16 predictive transcription factor motifs, Supplementary Fig. 9b). Among them we selected the top 3 peaks based on P-values—ERG(ETS), SOX10, and MITF.
Histone H3 lysine 9 acetylation influences MIC state through SOX10 motif
One of the top motifs associated with H3K9ac for cells cultured in regions of high curvature and perimeter/area is SOX10, a neural crest stem cell marker. Previous studies revealed that SOX10 played an important role in melanoma cell survival, proliferation, and metastasis27. It was also reported that the CD271 expression for malanoma, one of representative markers for the MIC state, was directly related to the expression of SOX1028. In addition, previous studies showed that MITF which could function as a melanoma oncogene was associated with melanoma progression29, and SOX10 is known to act upstream of MITF30, meaning that SOX10 may thus contribute to the melanoma-specific expression of genes associated with the MIC state. Interestingly, the enriched mouse phenotype annotations related to SOX10 family in H3K9ac peaks for reprogrammed cells suggest that increased tumor incidence and tumorigenesis are involved in their mouse phenotype. Furthermore, Nanog and SOX2 targets may be perturbed by the SOX10 family, suggesting the importance of SOX10 in activation of cells to the MIC state at the tumor periphery. Since we found that the SOX10 motif was enriched inside the differential histone peaks (Fig. 3b), we conducted immunofluorescence for SOX10 on our microaggreagates as well as ChIP-seq of SOX10. Cells cultured at the perimeter of microaggregates express higher levels of SOX10 compared to those cultured in central regions (Fig. 4a; Supplementary Fig. 10), and we see 14 differential peaks associated with cells cultured on patterned gels compared to those cultured on non-patterned gels. Some genes like Med27 and Trim14 inside H3K4me2 peaks were shown as one of the best differential SOX10 peaks associated with activated cells, and some peaks located nearby Klf12, Scml4, and Dync1li2 were intersected with differential H3K9 peaks (Supplementary Fig. 11). These genes may also be involved in malignant melanoma transformation. In addition, SOX10 appears to be binding a number of interesting genes in B16 melanoma as shown in the top enriched GO category regulating transcription as well as the other TFs that SOX10 binds nearby in cells, which could be playing a role in the transition (Supplementary Fig. 12).
Melanoma initiating cell phenotypes at the perimeter are directed by PR/SET domain-containing 14 (PRDM14)
To further confirm the association between the high ranked regulatory motifs (ERG (ETS), SOX10, and MITF for activated cells upregulating H3K9ac peaks) and regulation of downstream target genes, we identified H3K9ac differential peaks between two different conditions (reprogrammed and control cells). We first looked at the list of H3K9ac differential peaks to narrow down genes associated with cancer growth and progression. Among them, a number of these differential peaks were located in the regulatory domains of genes associated with cancer growth and progression and thus, we analyzed the expression of these genes for reprogrammed cells over control. Cells were cultured for 5 days on patterned substrates followed by lysis, RNA isolation and qPCR. Interestingly, activated cells cultured on patterned substrates show significantly higher expression of genes related to malignant melanoma such as CTGF (~5-fold) and NT5C2 (~3-fold) compared to cells cultured on non-patterned substrates (Fig. 4b). The most highly differentially expressed gene associated with H3K9ac/SOX10 is PRDM14 (~25-fold). PRDM14 is an epigenetic modifier involved in regulating pluripotency of stem cells with a clear role in modulating expression of core transcription factors Nanog, SOX2, and OCT431–35. PRDM14 is required to repress genes associated with lineage commitment and ensures naïve pluripotency in embryonic stem cells34. In addition, PRDM14 has been implicated in affecting the severity of several human cancers including breast36 and leukemia37 with evidence of a link to regulating a stem cell-like state37. To date PRDM14 has not been linked to tumorigenicity and the MIC state in melanoma. These findings are supported by the number of overlaps for peak co-occurrence of PRDM14 (pre-existing PRDM14 ChiP-seq data in the literature)38 with the H3K9ac and H3K4me2 marks from our study within 1000 bp, showing significant overlap with all of the peak sets and differential peak sets, except for PvsNP_k4me2 (Supplementary Table 1).
To explore how PRDM14 plays a supportive role in coordinating the epigenetic state of melanoma in response to perimeter geometry, we performed knockdowns of PRDM14 using siRNA. Knockdown was verified by qPCR and Western analysis using three different siRNAs against PRDM14 with a scrambled control (Supplementary Fig. 13a, b). PRDM14 knockdown resulted in a decrease in expression for genes linked to the MIC state; knockdown of PRDM14 led to complete abolishment of pluripotency markers SOX2, OCT4, and Nanog, and putative MIC markers CD271 and CD133; PRDM14 knockdown led to a partial decrease in Jarid1B expression (Fig. 4c), which was in line with the immunofluorescnence analysis displaying there may be a functional relation between PRDM14-mediated pluripotency and these specific histone modifications (Supplementary Fig. 13c). To confirm the localization of PRDM14 at perimeter features of micropatterned melanoma aggregates, we performed immunofluorescence characterization in both B16 cells and human primary melanoma cells. Fig. 4d shows perimeter enrichment of PRDM14 in the B16F0 cells and to a lesser extent the B16F10 cells. Both Melanoma B16F0 and B16F10 were all derived from C57B1/6 mice; the B16F0 model remains close to the parental B16F1 and grows slowly, whereas the B16F10 model is very aggressive, much more than the B16F0 model. The higher localization at the periphery in the B16F0 cells is consistent with a mechanism where PRDM14 is activated at the interface to reprogram cells of low metastatic potential to a highly metastatic MIC phenotype. To verify our observations in human cells, we chose to look at a primary human melanoma cell line (hMela). Human melanoma cells show significant enhancement in both CD271 and PRDM14 (Fig. 4d, e; Supplementary Fig. 13d), suggesting this mechanism is not unique to mouse cell lines but may play a role in guiding the MIC phenotype in human cells.
Discussion
In this paper we demonstrate how changes in specific histone marks at the perimeter of melanoma aggregates correspond to phenotypic alteration of melanoma cells to a stem cell-like MIC state. We show that stress exerted on microconfined cells at the periphery primes the melanoma phenotype through epigenetic reprogramming via histone modifications H3K9ac and H3K4me2, and involvement of the epigenetic modifier PRDM14. While we have shown how geometric cues can give rise to differential activity of PRDM14, it remains to be demonstrated how PRDM14 is activated based on these biophysical inputs. Furthermore, there are many other histone marks that remain to be profiled in order to map the complexity of epigenetic reprogramming in melanoma. For instance, a recent study demonstrated a link between H3K27me3 and mouse germ cell migration39. Nevertheless, our ChIP-seq analysis serves to illuminate how mechanotransduction can regulate the activity of stemness-related epigenetic modifiers including PRDM14 (Fig. 4c).
The mechanistic basis of geometry-driven epigenetic changes may be related to the response of tumors to their microenvironment, where intratumor pressure, extracellular mechanics, and curvature at the margin coordinate to provide a context in which mechanotransduction and downstream gene expression are regulated by these multivariate signals. Since these microenvironment parameters coincide with tumor angiogenesis19, it is important to consider the ramifications of transformation to a MIC state in proximity to pathways for metastasis. These findings may help guide researchers in further exploring epigenetic signatures for tumor malignancy, and the development of strategies to prevent, diagnose, and treat metastatic cancers.
Methods
Hydrogel fabrication
10 kPa polyacrylamide hydrogels (PA) were made as described previously14. Briefly, 10% acrylamide and 0.1% bis-acrylamide (Sigma) solution were prepared and mixed with initiators, 0.01% ammonium persulfate (APS, Sigma) and tetramethylethylenediamine (TEMED, Sigma), to initiate gelation. 20 µl of the mixture was sandwiched between a glass coverslip (18 mm, Fisher Scientific) functionalized with 3-aminopropyltriethoxysilane for 3 min and glutaraldehyde for 30 min (Sigma) and a hydrophobically treated glass slide to generate the even and homogeneous surface of gels on the activated coverslips. After around 25 min of gelation, the coverslips conjugated with gels were gently detached from the hydrophobically treated glass slide. Hydrazine hydrate (55%) chemistry was employed to modify the surface chemistry of PA gels and applied to the gels surface for 2 h with rocking, followed by washing with 5% glacial acetic acid for 1 h and distilled water for 1 h. PA gels fabricated on coverslips were stored at 4 °C for later use. Polydimethylsiloxane (PDMS, Polysciences) stamps were fabricated from silicon masters made by conventional photolithography for patterned or non-patterned shapes. To generate free aldehydes from oxidize sugar groups in matrix protein (fibronectin, Sigma), sodium periodate (~3.5 mg/ml, Sigma) for at least 45 min was employed. The protein solution was mounted onto patterned or non-patterned (flat surface) stamps for 30 min and dried with air. Micro-contact printing was used to transfer the protein residues on stamps to the gel surface (chemical conjugation).
Cell source and culture
The cancer cell lines B16F0 and B16F10 cells were purchased from American Type Culture Collection (ATCC) and cultured according to the recommended protocols. Media was changed every 3 to 4 days and cells were passaged at nearly 90% confluence using 0.25% trypsin (please see Supplementary Table 2 for reagent information). B16F0 cells were verified for mycoplasma contamination at Charles River Laboratories for cell line testing. De-identified human melanoma cell lines were a kind gift from John A. Copland III from the Mayo Clinic, Jacksonville, FL.
Immunofluorescence
B16F0, B16F10, or hMela cells were fixed using 4% paraformaldehyde for 20 min. Cells were permeabilized with 0.1% Triton X-100 for 30 min at room temperature and then blocked with 1% bovine serum for 15 min. Cells were stained with the appropriate primary and secondary antibodies (Supplementary Table 3). Before every step, cells were washed at least twice with PBS. Imaging was performed using an LSM 700 (Carl Zeiss, Inc.) four laser point scanning confocal microscope with a single pinhole for confocal imaging for fluorescence imaging.
RNA isolation and qPCR
Adherent cells on patterned gels (12 identical substrates for each condition) were lysed directly in TRIZOL reagent (Invitrogen). Total RNA was isolated by chloroform extraction and ethanol precipitation and amplified using TargetAmp™ 1-Round aRNA Amplification Kit 103 (Epicenter) according to vendor protocols. Superscript III® First Strand Synthesis System for qPCR (Invitrogen) was employed to reversely transcribe total RNA. qPCR was performed using SYBR® Green qPCR Master Mix (Invitrogen) on an Eppendorf Realplex 4S qPCR system. Primer sequences were in supplementary Table 4. All reactions were performed linearly by cycle number for each set of primers.
Western analysis
Cell extracts were isolated using RIPA buffer supplemented with protease and phosphatase inhibitors. Protein concentrations were determined by Nanodrop or BCA protein assay (Thermo Fisher Scientific), according to the company instructions. Subsequently, proteins were separated by 4–20% SDS-PAGE and electrophoretically transferred onto PVDF (Thermo Fisher Scientific) or nitrocellulose membranes (Bio-rad, Australia), which were then probed with primary antibodies overnight at 4 °C. HRP-conjugated secondary antibodies were detected by chemiluminescence agent ECL or Supersignal Western Dura Extended Duration (Thermo Fisher Scientific, Australia). Membranes were imaged by ImageQuant LAS4000 (GE healthcare, Sweden). Densitometric analysis was performed by ImageQuant TL Software (GE healthcare) and presented as ratios of protein expression normalized to relevant GAPDH or β-actin loading control.
RNA Interference
The siRNAs for Jarid1B (ID 75605, Trilencer-27 Mouse siRNA, siRNA A: SR422988A, siRNA B: SR422988B, and siRNA C: SR422988C) or scrambled siRNAs (SR30004) as well as PRDM14 (ID 383491, Trilencer-27 Mouse siRNA, siRNA A: SR417406A, siRNA B: SR417406B, and siRNA C: SR417406C) or scrambled (SR30004) were purchased from OriGene. Transfection was performed according to the vendor’s instructions. Lipofectamine 2000™ was employed for higher transfection efficiency. Cells cultured for 5 days in patterned substrates were treated with siRNA twice at day 1 and day 3.
Cell labeling and flow cytometry
B16F0 cells cultured for five days on spiral-patterned or non-patterned gels (12 identical substrates for each condition) were isolated from substrates by trypsin, followed by breaking down into a single cell suspension. Cells were fixed in 4% paraformaldehyde for 20 min and then permeabilized in 0.1% Triton X-100 in PBS for 30 min. After blocking cells in 1% BSA in PBS for 1 h, Cells were stained with primary antibodies in 1% BSA in PBS overnight at 4 °C and then secondary antibodies in 2% goat serum, 1% BSA in PBS for 20 min in a humid chamber (5% CO2 and 37 °C). Before every step, cells were rinsed at least three times with PBS. A BD LSR Fortessa Flow Cytometry Analyzer was used to perform flow cytometry analysis. To set the baseline, negative controls were prepared by staining cells without primary antibodies.
Microscopy data analysis
Confocal images were analyzed using ImageJ software. Multiple cells were imaged for each condition and fluorescence intensities of single cells in different regions of patterns (after background subtraction) were used to compare marker expression. For generating immunofluorescence heatmaps, cells cultured on various shapes were fixed, stained, and imaged on the same day using the same settings. After subtraction of background intensities of raw fluorescent images, patterns were aligned in ImageJ with the same orientation as cultured across the surface, followed by incorporating into a Z stack with the average intensity calculated for heatmap generation.
Chromatin immunoprecipitation and sequencing (Chip-seq)
H3K4me2 and H3K9ac ChiP samples were prepared from B16F0 cells cultured on patterned or non-patterned substrates, and ChiP DNA quality was verified as previously described40. B16 melanoma cells were cultured for five days and then fixed with 1% formaldehyde for 10 min at room temperature. Fixations were quenched by glycine (125 mM), followed by washing cells with cold 1x PBS two times. Cells were treated with hypotonic lysis buffer for 10 min (20 mM HEPES at pH 7.9, 10 mM KCl, 1 mM EDTA at pH 8, 10% glycerol, 1 mM DTT, 0.5 mM PMSF, 0.1 mM sodium orthovanadate, and 1X Roche protease inhibitors). Collected nuclear pellets were lysed in in 1× RIPA buffer (10 mM Tris-Cl at pH 8.0, 140 mM NaCl, 1% Triton X-100, 0.1% SDS, 1% deoxycholic acid, 0.5 mM PMSF, 1 mM DTT, 0.1 mM sodium orthovanadate, and Roche protease inhibitors). Nuclear lysates were sonicated with a Branson 250 Sonifier (output 20%, 100% duty cycle) to shear the chromatin to ∼1 Kb in size. Clarified lysates were incubated overnight at 4 °C with anti-H3K4me2 (Cell Signaling, 9725) or H3K9ac (Cell Signaling, 9649) antibodies. Protein–DNA complexes were precipitated, immunoprecipitates were washed three times in 1× RIPA, once in 1× PBS, and then eluted from the beads by addition of 1% SDS, 1× TE (10 mM Tris-Cl at pH 7.6, 1 mM EDTA at pH 8), and incubated for 10 min at 65 °C. Cross-links were reversed overnight at 65 °C. Purification for all samples were performed by treatment first with 200 μg/mL RNase A for 1 h at 37 °C, then with 200 μg/mL Proteinase K for 2 h at 45 °C, followed by extraction with phenol:chloroform:isoamyl alcohol and precipitation at −70 °C with 0.1 volume of 3 M sodium acetate, 2 volumes of 100% ethanol, and 1.5 μL of pellet paint coprecipitant. ChIP DNA prepared from 1 × 107 cells was resuspended in 50 μL of ultrapure water. Sequencing (an Illumina HiSeq 2500 sequencer using a TruSeq SBS sequencing kit, version 4) was performed and Fastq files were obtained and demultiplexed with the bcl2fastq v2.17.1.14 Conversion Software (Illumina). The sequencing data from this study have been submitted to the NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/).
Chip-seq data analysis
ChIP-seq bioinformatics analyses were performed. Sequence data were mapped with Bowtie2 (Langmead and Salzberg 2012) to the UCSC Mus musculus mm9 genome, using default settings. Mapped sequence data were analyzed for peaks using HOMER (Hypergeometric Optimization of Motif EnRichment) v4.7 (Heinz et al. 2010). Samples were converted into tag directories, and QC was performed using read mapping and GC bias statistics. Histone peaks were then called from the Tag Directories with default factor settings, except local filtering was disabled (-L 0) and input filtering was set at three-fold over background (-F 3), to increase the sensitivity of the peak calling and identify individual subunits of multihistone peaks. After peak calling, peak files were annotated to the mouse mm9 genome using HOMER’s annotation script to assign peaks to genes, and associate peaks with differential expression data. BigWiggle pileup files were generated using HOMER’s makeBigWig.pl script with default settings. Differential chromatin peaks were identified using the HOMER getDifferentialPeak.pl script, looking for any peaks that changed at least two-fold between conditions with a significance cutoff of 1 × 10–4. Genes annotated nearby differential peaks were submitted for GO analysis to DAVID and GREAT. Motif Analysis was performed with the HOMER findMotifsGenome.pl script using default settings.
Statistics and reproducibility
Data were obtained at least three independent experiments and error bars represent standard deviation around the mean unless otherwise specified. For comparing statistics between two groups or more than two groups, student’s t-test or analysis of variance (ANOVA) with Tukey HSD Post-hoc testing, respectively, were employed. Differences were considered significant at P < 0.05.
Reporting summary
Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Supplementary information
Acknowledgements
This research was supported with funding from the American Cancer Society Illinois Division Grant # 281225, the National Science Foundation Grant # 1454616 CAR, and the National Health and Medical Research Council, Grant ID APP1185021. CHS was supported by #SFLife 291812 from the Simons Foundation. We gratefully acknowledge the support by Prof. Lisa J. Stubbs from the Department of Cell and Developmental Biology, University of Illinois at Urbana-Champaign. We also thank the Institute of Genomic Biology Imaging facilities, Micro, Nanotechnology Laboratory facilities, and the Roy J. Carver Biotechnology Center.
Author contributions
J.L. and K.A.K. conceived the ideas and designed the experiments. J.L., T.G.M., C.H.S., A.A.A., H.Z., X.W., and H.G. conducted the experiments and J.L., T.G.M., C.H.S., A.A.A., J.Y., K.G., and K.A.K. analyzed the data. All authors interpreted the data and wrote the manuscript.
Data availability
Genome-wide maps of chromatin state in mouse B16 melanoma cancer cells in response to interfacial geometry were submitted to the GEO accession numbers GSE146444. The authors declare that all data supporting the findings of this study are available within the article, its Supplementary Information file and from the corresponding author on reasonable request. The source data underlying the graphs presented in the main and supplementary figures are shown as Supplementary Data 1. The uncropped western blot images corresponding to Fig. 2d and Supplementary Fig. 13b are shown in Supplementary Figs. 14 and 15, respectively.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Supplementary information is available for this paper at 10.1038/s42003-020-1067-1.
References
- 1.Nowell PC. The clonal evolution of tumor cell populations. Science. 1976;194:23–28. doi: 10.1126/science.959840. [DOI] [PubMed] [Google Scholar]
- 2.Esteller M. Cancer epigenetics: DNA methylation and chromatin alterations in human cancer. Adv. Exp. Med. Biol. 2003;532:39–49. doi: 10.1007/978-1-4615-0081-0_5. [DOI] [PubMed] [Google Scholar]
- 3.Goldberg AD, Allis CD, Bernstein E. Epigenetics: a landscape takes shape. Cell. 2007;128:635–638. doi: 10.1016/j.cell.2007.02.006. [DOI] [PubMed] [Google Scholar]
- 4.Feinberg AP, Tycko B. The history of cancer epigenetics. Nat. Rev. Cancer. 2004;4:143–153. doi: 10.1038/nrc1279. [DOI] [PubMed] [Google Scholar]
- 5.Core LJ, Waterfall JJ, Lis JT. Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters. Science. 2008;322:1845–1848. doi: 10.1126/science.1162228. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Schuettengruber B, Chourrout D, Vervoort M, Leblanc B, Cavalli G. Genome regulation by polycomb and trithorax proteins. Cell. 2007;128:735–745. doi: 10.1016/j.cell.2007.02.009. [DOI] [PubMed] [Google Scholar]
- 7.Schatton T, et al. Identification of cells initiating human melanomas. Nature. 2008;451:345–349. doi: 10.1038/nature06489. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer. 2008;8:755–768. doi: 10.1038/nrc2499. [DOI] [PubMed] [Google Scholar]
- 9.Meacham CE, Morrison SJ. Tumour heterogeneity and cancer cell plasticity. Nature. 2013;501:328–337. doi: 10.1038/nature12624. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Hjelmeland AB, et al. Acidic stress promotes a glioma stem cell phenotype. Cell Death Differ. 2011;18:829–840. doi: 10.1038/cdd.2010.150. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Lagadec C, Vlashi E, Della Donna L, Dekmezian C, Pajonk F. Radiation-induced reprogramming of breast cancer cells. Stem Cells. 2012;30:833–844. doi: 10.1002/stem.1058. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Pang MF, et al. Tissue stiffness and hypoxia modulate the integrin-linked kinase ilk to control breast cancer stem-like cells. Cancer Res. 2016;76:5277–5287. doi: 10.1158/0008-5472.CAN-16-0579. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Heddleston JM, Li Z, McLendon RE, Hjelmeland AB, Rich JN. The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle. 2009;8:3274–3284. doi: 10.4161/cc.8.20.9701. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Lee J, Abdeen AA, Wycislo KL, Fan TM, Kilian KA. Interfacial geometry dictates cancer cell tumorigenicity. Nat. Mater. 2016;15:856–862. doi: 10.1038/nmat4610. [DOI] [PubMed] [Google Scholar]
- 15.Klein BJ, et al. The histone-H3K4-specific demethylase KDM5B binds to its substrate and product through distinct PHD fingers. Cell Rep. 2014;6:325–335. doi: 10.1016/j.celrep.2013.12.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Li Q, et al. Binding of the JmjC demethylase JARID1B to LSD1/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14. Cancer Res. 2011;71:6899–6908. doi: 10.1158/0008-5472.CAN-11-1523. [DOI] [PubMed] [Google Scholar]
- 17.Roesch A, et al. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell. 2010;141:583–594. doi: 10.1016/j.cell.2010.04.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Yoshida M, et al. PLU1 histone demethylase decreases the expression of KAT5 and enhances the invasive activity of the cells. Biochem. J. 2011;437:555–564. doi: 10.1042/BJ20110343. [DOI] [PubMed] [Google Scholar]
- 19.Lee J, et al. Melanoma topology reveals a stem-like phenotype that promotes angiogenesis. Sci. Adv. 2017;3:e1701350. doi: 10.1126/sciadv.1701350. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Shahbazian MD, Grunstein M. Functions of site-specific histone acetylation and deacetylation. Annu. Rev. Biochem. 2007;76:75–100. doi: 10.1146/annurev.biochem.76.052705.162114. [DOI] [PubMed] [Google Scholar]
- 21.Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis. 2009;31:27–36. doi: 10.1093/carcin/bgp220. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.von Burstin J, et al. E-cadherin regulates metastasis of pancreatic cancer in vivo and is suppressed by a SNAIL/HDAC1/HDAC2 repressor complex. Gastroenterology. 2009;137:361–371. doi: 10.1053/j.gastro.2009.04.004. [DOI] [PubMed] [Google Scholar]
- 23.Hollenhorst PC, et al. Oncogenic ETS proteins mimic activated RAS/MAPK signaling in prostate cells. Genes Dev. 2011;25:2147–2157. doi: 10.1101/gad.17546311. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Rothhammer T, et al. The Ets-1 transcription factor is involved in the development and invasion of malignant melanoma. Cell. Mol. Life Sci. 2004;61:118–128. doi: 10.1007/s00018-003-3337-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Spangler B, et al. ETS-1/RhoC signaling regulates the transcription factor c-Jun in melanoma. Int. J. Cancer. 2012;130:2801–2811. doi: 10.1002/ijc.26277. [DOI] [PubMed] [Google Scholar]
- 26.Ben-batalla I, et al. Deregulation of the Pit-1 transcription factor in human breast cancer cells promotes tumor growth and metastasis. J. Clin. Invest. 2010;120:4289–4302. doi: 10.1172/JCI42015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Tudrej KB, Czepielewska E, Kozłowska-wojciechowska M. State of the art paper SOX10-MITF pathway activity in melanoma cells. Arch. Med. Sci. 2017;133:1493–1503. doi: 10.5114/aoms.2016.60655. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Shakhova O, et al. Sox10 promotes the formation and maintenance of giant congenital naevi and melanoma. Nat. Cell Biol. 2012;14:882–890. doi: 10.1038/ncb2535. [DOI] [PubMed] [Google Scholar]
- 29.Garraway LA, et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature. 2005;436:117–122. doi: 10.1038/nature03664. [DOI] [PubMed] [Google Scholar]
- 30.Potterf SB, Furumura M, Dunn KJ, Arnheiter H, Pavan WJ. Transcription factor hierarchy in Waardenburg syndrome: Regulation of MITF expression by SOX10 and PAX3. Hum. Genet. 2000;107:1–6. doi: 10.1007/s004390000328. [DOI] [PubMed] [Google Scholar]
- 31.Burton A, et al. Single-cell profiling of epigenetic modifiers identifies PRDM14 as an inducer of cell fate in the mammalian embryo. Cell Rep. 2013;5:687–701. doi: 10.1016/j.celrep.2013.09.044. [DOI] [PubMed] [Google Scholar]
- 32.Ma Z, Swigut T, Valouev A, Rada-Iglesias A, Wysocka J. Sequence-specific regulator Prdm14 safeguards mouse ESCs from entering extraembryonic endoderm fates. Nat. Struct. Mol. Biol. 2011;18:120–128. doi: 10.1038/nsmb.2000. [DOI] [PubMed] [Google Scholar]
- 33.Gillich A, et al. Epiblast stem cell-based system reveals reprogramming synergy of germline factors. Cell Stem Cell. 2012;10:425–439. doi: 10.1016/j.stem.2012.01.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Yamaji M, et al. Critical function of Prdm14 for the establishment of the germ cell lineage in mice. Nat. Genet. 2008;40:1016–1022. doi: 10.1038/ng.186. [DOI] [PubMed] [Google Scholar]
- 35.Okashita N, et al. PRDM14 drives OCT3/4 recruitment via active demethylation in the transition from primed to naive pluripotency. Stem Cell Rep. 2016;7:1072–1086. doi: 10.1016/j.stemcr.2016.10.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Nishikawa N, et al. Gene amplification and overexpression of PRDM14 in breast cancers. Cancer Res. 2007;67:9649–9657. doi: 10.1158/0008-5472.CAN-06-4111. [DOI] [PubMed] [Google Scholar]
- 37.Dettman EJ, et al. Prdm14 initiates lymphoblastic leukemia after expanding a population of cells resembling common lymphoid progenitors. Oncogene. 2011;30:2859–2873. doi: 10.1038/onc.2011.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Chia NY, et al. A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity. Nature. 2010;468:316–320. doi: 10.1038/nature09531. [DOI] [PubMed] [Google Scholar]
- 39.Mallol A, Guirola M, Payer B. PRDM14 controls X-chromosomal and global epigenetic reprogramming of H3K27me3 in migrating mouse primordial germ cells. Epigenetics Chromatin. 2019;12:38. doi: 10.1186/s13072-019-0284-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Saul MC, et al. Transcriptional regulatory dynamics drive coordinated metabolic and neural response to social challenge in mice. Genome Res. 2017;27:959–972. doi: 10.1101/gr.214221.116. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Genome-wide maps of chromatin state in mouse B16 melanoma cancer cells in response to interfacial geometry were submitted to the GEO accession numbers GSE146444. The authors declare that all data supporting the findings of this study are available within the article, its Supplementary Information file and from the corresponding author on reasonable request. The source data underlying the graphs presented in the main and supplementary figures are shown as Supplementary Data 1. The uncropped western blot images corresponding to Fig. 2d and Supplementary Fig. 13b are shown in Supplementary Figs. 14 and 15, respectively.